Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Canada-based psychedelics manufacturing company, has inked its first commercial sale to the prestigious Hadassah BrainLabs, also known as the Center for Psychedelics Research at the Hadassah Medical Center at Hebrew University in Jerusalem. 

The company’s CEO Chris McElvany says the sale marks “a key operational milestone” and establishes its ability as a global supplier of products and services.

See also: Lucy Scientific Discovery Plans To Manufacture …

Full story available on